Burning Rock Biotech (NASDAQ:BNR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Burning Rock Biotech Stock (NASDAQ: BNR) stock price, news, charts, stock research, profile.

Open	$6.02
Close	$6.58
Volume / Avg.	13.78K / 34.13K
Day Range	$5.96 - $7.00
52 Wk Range	2.62 - 9.99
Market Cap	$70.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	0.81%
Days to Cover	3.46

Recent News

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?

Key Takeaways: Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third quarter amid an industry crackdown, spotlighting a major risk for Chinese companies By Doug Young

The Bamboo Works

New Horizon Health Finds Formula For Profits Ahead Of Schedule

Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$6.02
Close	$6.58
Volume / Avg.	13.78K / 34.13K
Day Range	$5.96 - $7.00
52 Wk Range	2.62 - 9.99
Market Cap	$70.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	0.81%
Days to Cover	3.46

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Burning Rock Biotech (BNR) stock?

You can purchase shares of Burning Rock Biotech (NASDAQ:BNR) through any online brokerage.

View our list of the best stock brokerages

Who are Burning Rock Biotech (BNR) competitors?

Other companies in Burning Rock Biotech’s space includes: Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP), Inovio Pharmaceuticals (NASDAQ:INO), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).

What is the forecast, or price target, for Burning Rock Biotech (BNR) stock?

There is no analysis for Burning Rock Biotech to provide a consensus price target.

What is the current price for Burning Rock Biotech (BNR)?

The stock price for Burning Rock Biotech (NASDAQ: BNR) is $6.84 last updated December 10, 2024 at 8:03 AM EST.

Does Burning Rock Biotech (BNR) pay a dividend?

There are no upcoming dividends for Burning Rock Biotech.

When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?

Burning Rock Biotech’s Q3 earnings are confirmed for Friday, January 3, 2025.

Is Burning Rock Biotech (BNR) going to split?

There is no upcoming split for Burning Rock Biotech.

What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Burning Rock Biotech

Burning Rock Biotech (BNR) Forecast